Spike Protein News and Research

RSS
Super-antibody UT28K shows broad-spectrum activity against SARS-CoV-2 variants

Super-antibody UT28K shows broad-spectrum activity against SARS-CoV-2 variants

CDC study reveals hybrid SARS-CoV-2 spike from Delta/Omicron recombination event

CDC study reveals hybrid SARS-CoV-2 spike from Delta/Omicron recombination event

Investigating effectiveness of mRNA booster against SARS-CoV-2 Omicron in individuals primed with mRNA or inactivated virus vaccines

Investigating effectiveness of mRNA booster against SARS-CoV-2 Omicron in individuals primed with mRNA or inactivated virus vaccines

Cost-effective ovine antibody-based therapy against SARS-CoV-2 infection

Cost-effective ovine antibody-based therapy against SARS-CoV-2 infection

T-cell responses after COVID-19 and vaccinations

T-cell responses after COVID-19 and vaccinations

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

Discovery of host co-factors necessary for SARS-CoV2 infection

Discovery of host co-factors necessary for SARS-CoV2 infection

Study shows efficacy of COVID-19 vaccine in people receiving cancer treatment

Study shows efficacy of COVID-19 vaccine in people receiving cancer treatment

Unique binding property may explain the ability of delta variant to spread more rapidly

Unique binding property may explain the ability of delta variant to spread more rapidly

Using virtual reality headsets to instruct UTSA students about protein structures

Using virtual reality headsets to instruct UTSA students about protein structures

Research highlight reports on the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2

Research highlight reports on the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2

mRNA boosters enhance neutralization of SARS-CoV-2 BA.1, BA.2 and BA.3

mRNA boosters enhance neutralization of SARS-CoV-2 BA.1, BA.2 and BA.3

Third BNT162b2 dose elicits more durable immune response than second dose

Third BNT162b2 dose elicits more durable immune response than second dose

Using PCR-based genotyping to detect SARS-CoV-2 delta-omicron coinfection

Using PCR-based genotyping to detect SARS-CoV-2 delta-omicron coinfection

ZF2001 vaccine safe and effective against symptomatic and severe-to-critical COVID

ZF2001 vaccine safe and effective against symptomatic and severe-to-critical COVID

Infection with SARS-CoV-2 results in antibodies against common colds

Infection with SARS-CoV-2 results in antibodies against common colds

A guide to help you keep up with the omicron subvariants

A guide to help you keep up with the omicron subvariants

Marine bioactive compounds against SARS-CoV-2

Marine bioactive compounds against SARS-CoV-2

Evaluating the findings of phase 3 clinical trial of plant-based COVID-19 vaccine

Evaluating the findings of phase 3 clinical trial of plant-based COVID-19 vaccine

Study identifies two new Omicron lineages associated with a resurgence in infections in South Africa

Study identifies two new Omicron lineages associated with a resurgence in infections in South Africa